According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy (Source: https://www1.racgp.org.au/ajgp/2021/october/medicinal-cannabis)
Australian Health Journal met with 3 speakers at the recent @arcsaustralia ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
-
Startup Advances Biosensing
Melbourne based Nutromics is looking to solve some of the biggest healthcare challenges, by delivering on a mission to revolutionise precision medicine with Continuous Molecular Monitoring (CMM). Nutromics is developing biosensor technology integrated into a small and unobtrusive wearable smart patch.The software solution aims to be flexible and designed to connect with mobile and web solutions for integration with consumer health software and hospital platforms.
-
Artificial Intelligence (AI) & data skilling clinicians
In this first release, world renowned AI and medical data science experts Dr Anthony Chang and Professor Enrico Coiera spoke to Australian Health Journal reporter Anne Dao at AIMed 2019 Sydney. The conference aimed at clinicians and non-clinicians discussed current clinical applications of Artificial Intelligence in medical imaging, decision support, use of predictive healthcare and machine learning.
-
Clinical research integrates with GP and Pharmacist workflows to supplement practice revenue
Clinical trials are crucial to the development of evidence-based preventative medicines. In addition, participation in clinical trials can also provide patients with opportunities to access new treatments.
“Clinical trials are at the heart of medical advances which look into new ways to treat, prevent, or detect disease. Volunteers often do so to help contribute to advancing scientific research, knowing that they are participating in the hope of helping future generations,” said Charlotte Bradshaw, CEO and Founder to Evrima Technologies.
